All Journals > Clinical Infectious Diseases > 15 May 2008 > Impact of HIV Tropism

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 May 2008

Volume 46, Number 10
Clinical Infectious Diseases 2008;46:1617–1623
© 2008 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2008/4610-0021$15.00
HIV/AIDS MAJOR ARTICLE

The Impact of HIV Tropism on Decreases in CD4 Cell Count, Clinical Progression, and Subsequent Response to a First Antiretroviral Therapy Regimen

Laura Waters,

Sundhiya Mandalia,

Paul Randell,

Adrian Wildfire,

Brian Gazzard, and

Graeme Moyle

St. Stephens AIDS Trust, Department of Genitourinary/HIV Medicine, Chelsea and Westminster Hospital, London, United Kingdom

Background.Human immunodeficiency virus (HIV) uses 2 distinct chemokine receptors, CCR5 (R5) or CXCR4 (X4), during entry. Viruses may be R5 tropic, X4 tropic, or dual/mixed (D/M) tropic. R5‐tropic virus predominates at high CD4 cell counts, with the number of X4‐tropic strains increasing as CD4 cell count decreases.

Methods.We investigated the relationship between tropism and decreases in CD4 cell count before antiretroviral therapy initiation, the frequency of clinical events, and responses to antiretroviral therapy in a cohort of treatment‐naive patients.

Results.Four hundred two treatment‐naive patients underwent tropism determination; 326 harbored R5‐tropic virus, and 76 harbored X4‐ or D/M‐tropic virus. After adjustment for baseline characteristics, the rate of decrease in CD4 cell count was significantly greater in patients infected with X4‐ or D/M‐tropic virus at 12 months ( ). Two hundred twenty‐nine individuals infected with R5‐tropic virus and 60 individuals infected with X4‐ or D/M‐tropic virus commenced antiretroviral therapy between tropism testing and the time of data analysis. Time to viral suppression and the proportion of patients achieving viral suppression were similar at 6, 12, and 24 months. CD4 cell count increases were similar. Clinical events were significantly more common in the group infected with X4‐ or D/M‐tropic virus. Multivariate analysis demonstrated a relative risk of experiencing a clinical event of 2.56 (95% confidence interval, 1.37–4.76; ) among patients infected with X4‐ or D/M‐tropic virus.

Conclusions.The presence of D/M‐ or X4‐tropic virus has a deleterious effect on CD4 cell count decrease and risk of clinical disease. Response to standard antiretroviral therapy is not affected by viral tropism.

Received 13 August 2007; accepted 24 December 2007; electronically published 14 April 2008.

Reprints or correspondence: Dr. Graeme Moyle, St. Stephens Centre, Chelsea & Westminster Hospital, 369 Fulham Rd., London SW10 9NH, United Kingdom ().

Cited by

P. Frange, J. Galimand, C. Goujard, C. Deveau, J. Ghosn, C. Rouzioux, L. Meyer, M.-L. Chaix. (2009) High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study. Journal of Antimicrobial Chemotherapy 64:1, 135-141
Online publication date: 1-Aug-2009.
CrossRef
Daniel R Kuritzkes. (2009) HIV-1 entry inhibitors: an overview. Current Opinion in HIV and AIDS 4:2, 82-87
Online publication date: 1-Apr-2009.
CrossRef
Michael M Lederman, Jose Este. (2009) Targeting a host element as a strategy to block HIV replication: is it nice to fool with Mother Nature?. Current Opinion in HIV and AIDS 4:2, 79-81
Online publication date: 1-Apr-2009.
CrossRef
Matthew Bidwell Goetz, Robert Leduc, Jay R Kostman, Ann M Labriola, Yolanda Lie, Jodi Weidler, Eoin Coakley, Michael Bates, Roberta Luskin-Hawk. (2009) Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 50:3, 259-266
Online publication date: 1-Apr-2009.
CrossRef
Graeme Moyle, Edwin DeJesus, Marta Boffito, Rebecca S. Wong, Colleen Gibney, Karin Badel, Ron MacFarland, Gary Calandra, Gary Bridger, and Stephen Becker, for the X4 Antagonist Concept Trial Study Team. (2009) Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4‐Tropic HIV Type 1. Clinical Infectious Diseases 48:6, 798-805
Online publication date: 15-Mar-2009.
Abstract-Full Text-PDF Version (297 kB)
Harold Burger and Donald Hoover. (2008) HIV‐1 Tropism, Disease Progression, and Clinical Management. The Journal of Infectious Diseases 198:8, 1095-1097
Online publication date: 15-Oct-2008.
Citation-Full Text-PDF Version (48 kB)
Back to Top
Close Popup